(Reuters) - Pfizer received a so-called approvable letter from the Food and Drug Administration for the twice-a-day pill that is the first drug designed to keep the HIV virus that causes AIDS from entering healthy immune cells. Older AIDS medicines attack the virus itself.
The company said it was in discussions with the FDA to address the agency's outstanding questions and finalize the product labeling as soon as possible.
Read more at Reuters.com Government Filings News
The company said it was in discussions with the FDA to address the agency's outstanding questions and finalize the product labeling as soon as possible.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment